OneSource Specialty Pharma Limited (BOM:544292)

Market Cap	186.52B -22.8%
Revenue (ttm)	14.22B -1.6%
Net Income	-738.03M
EPS	-6.44
Shares Out	n/a
PE Ratio	n/a
Forward PE	41.78
Dividend	n/a
Ex-Dividend Date	n/a

Volume	28,306
Open	1,617.75
Previous Close	1,615.10
Day's Range	1,610.80 - 1,688.10
52-Week Range	1,075.00 - 2,082.10
Beta	n/a
Analysts	Buy
Price Target	2,036.75 (+21.84%)
Earnings Date	Jul 24, 2026

About BOM:544292

OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India, Ireland, the United States, and internationally. The company provides end-to-end contract development and manufacturing operations (CDMO) services across various phases of preclinical and clinical development and commercial supply of biologics. It also offers drug-devices, including prefilled syringes, dial and push variable and fixed dose pe...

• Industry: Commercial Physical and Biological Research
• Founded: 2007
• Employees: 1,412
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544292

Financial Performance

In fiscal year 2026, BOM:544292's revenue was 14.22 billion, a decrease of -1.61% compared to the previous year's 14.45 billion. Losses were -738.03 million, 310.7% more than in 2025.

Analyst Summary

According to 4 analysts, the average rating for 544292 stock is "Buy." The 12-month stock price target is ₹2,037, which is an increase of 21.84% from the latest price.

Price Target

₹2,037

(21.84% upside)

Analyst Consensus: Buy

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 13, 2026

Data Sources Report a data error